OTCMKTS:ALIOF ALIOF (ALIOF) Stock Price, News & Analysis $278.50 0.00 (0.00%) As of 09/27/2022 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About ALIOF Stock (OTCMKTS:ALIOF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get ALIOF alerts:Sign Up Key Stats Today's Range$278.50▼$278.5050-Day Range$278.50▼$278.5052-Week Range$138.01▼$286.30VolumeN/AAverage Volume924 shsMarket Capitalization$29.89 billionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewActelion Ltd. develops, produces and markets pharmaceutical drugs. The firm engages in research, development, manufacturing, and distribution of pharmaceutical, biological, and diagnostic products. The company was founded by Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Müller and Thomas Widmann on December 30, 1999 and is headquartered in Allschwil, Switzerland.Read More… Receive ALIOF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ALIOF and its competitors with MarketBeat's FREE daily newsletter. Email Address ALIOF Stock News HeadlinesDolce & Gabbana’s launches Rs 9,000 dog perfume. Why some vets and pet owners are skepticalAugust 9, 2024 | msn.comDolce & Gabbana launches perfume for dogs, but some vets are skepticalAugust 8, 2024 | msn.comTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve suffered financial hardship…Our President may have solved everything.May 22, 2025 | Paradigm Press (Ad)$108 Perfume Launched for Dogs—Not Everyone Is ConvincedAugust 8, 2024 | msn.comDolce & Gabbana launches $108 dog cologne, raising hackles of some vets and pet ownersAugust 8, 2024 | msn.comPaw-fume: Dolce & Gabbana's scent for dogs, but some vets unsure it's safeAugust 8, 2024 | mirror.co.ukDolce & Gabbana launches a new perfume for dogs, but some vets and pet-owners are skepticalAugust 8, 2024 | msn.com5 Things You Must Know Before the Market Opens FridayAugust 24, 2023 | thestreet.comSee More Headlines ALIOF Stock Analysis - Frequently Asked Questions How have ALIOF shares performed this year? ALIOF's stock was trading at $278.50 on January 1st, 2025. Since then, ALIOF shares have increased by 0.0% and is now trading at $278.50. View the best growth stocks for 2025 here. How were ALIOF's earnings last quarter? ALIOF (OTCMKTS:ALIOF) posted its quarterly earnings data on Monday, February, 16th. The company reported $0.87 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.09 by $0.22. The firm had revenue of $501.50 million for the quarter, compared to the consensus estimate of $546.30 million. How do I buy shares of ALIOF? Shares of ALIOF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings2/16/2015Today5/22/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medicinals & Botanicals Sub-IndustryN/A Current SymbolOTCMKTS:ALIOF CIKN/A Webwww.actelion.com Phone(161) 565-6565Fax41-61-565-6500EmployeesN/AYear Founded1997Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares107,330,000Free FloatN/AMarket Cap$29.89 billion OptionableNot Optionable BetaN/A Social Links 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report This page (OTCMKTS:ALIOF) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredWashington Is Broke—and Eyeing Your Savings NextWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALIOF Please log in to your account or sign up in order to add this asset to your watchlist. Share ALIOF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.